首页> 外国专利> VACCINE ADJUVANT TO WHICH IL-15 GENE IS APPLIED

VACCINE ADJUVANT TO WHICH IL-15 GENE IS APPLIED

机译:应用IL-15基因的疫苗佐剂

摘要

PROBLEM TO BE SOLVED: To provide a vaccine adjuvant characterized by containing IL-15 gene.;SOLUTION: It is assumed that IL-15 not only acts as a factor for proliferating NK cells, NKT cells and γδ type intestinal epithelial lymphocytes which bear an early induction reaction but also plays an important role for the maintenance of memory type CD8+T cells. Killer CD8+memory T cells play an important role for tuberculous infection protection, and the proliferation and maintenance of the CD8+killer cells are most important for a tuberculous infection protection mechanism. On the basis of the backgrounds, it is aimed to induce strong tubercule bacillus specific CD8+T cells capable of being maintained for a long period by the combination of the BCG vaccine with IL-15. The effective vaccine adjuvant for enhancing the effect of the vaccine is provided.;COPYRIGHT: (C)2003,JPO
机译:解决的问题:提供一种以含有IL-15基因为特征的疫苗佐剂。解决方案:假定IL-15不仅充当NK细胞,NKT细胞和γ增殖的因子。 2型小肠上皮淋巴细胞不仅具有早期诱导反应,而且在记忆型CD8 + T细胞的维持中也起着重要作用。杀伤性CD8 +记忆性T细胞在保护结核感染中起着重要作用,而CD8 +杀伤性细胞的增殖和维持对于结核性感染的保护机制最为重要。在背景的基础上,本发明的目的是诱导通过BCG疫苗与IL-15的组合能够长期维持的强结核杆菌特异性CD8 + T细胞。提供了增强疫苗效果的有效疫苗佐剂。;版权所有:(C)2003,日本特许厅

著录项

  • 公开/公告号JP2003026599A

    专利类型

  • 公开/公告日2003-01-29

    原文格式PDF

  • 申请/专利权人 UNIV NAGOYA;

    申请/专利号JP20010175897

  • 发明设计人 KIKKAI YASUNOBU;

    申请日2001-06-11

  • 分类号A61K39/39;A61K39/04;A61P31/06;

  • 国家 JP

  • 入库时间 2022-08-22 00:13:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号